#Immuno Oncology Assays Kit Market

[ilmemcmi]

Spatial Omics Market Increasing Adoption of Spatial Omics in Drug Discovery and Diagnostics

Spatial omics refers to technologies that help localize gene expression and other molecular information in cells and tissues at subcellular resolution to analyze biological systems. Spatial omics allows simultaneous mapping of multiple targets in intact biological tissues to understand complex biological processes and disease pathogenesis. The technology helps obtain genomic, transcriptomic and proteomic details from specific cell types or structures within tissues. This provides better insights compared to conventional bulk-omics techniques that generate averaged measurements from biological samples containing mixed cell populations. With its ability to generate molecular spatial information while preserving tissue architecture, spatial omics is finding rising application in drug discovery, diagnostics and clinical research. Global spatial omics market is estimated to be valued at USD 315.5 Mn in 2024 and is expected to exhibit a CAGR of 9.4% during the forecast period (2024-2031).

Growing use of spatial omics techniques like spatial transcriptomics, mass spectrometry imaging and others in academic and pharmaceutical research is a key factor driving market growth. Spatial Omics Market Growth is being widely adopted by pharmaceutical companies for target identification and validation, biomarker discovery, toxicity prediction and drug efficacy evaluation during preclinical development. It is also finding increasing use in clinical applications like cancer diagnostics, immuno-oncology and neuroscience research. Spatial information helps gain a better understanding of tissue heterogeneity, cellular interactions and biomarker correlations, fueling demand for spatial omics technologies. Key Takeaways Key players operating in the spatial omics market are Gilson Company, Inc., Russell Finex Ltd., Retsch GmbH, Lao Soung Machinery Co. Ltd., Endecotts Ltd., Bionics Scientific Technologies Ltd., and Thermo Fischer Scientific, Advantech Manufacturing, Dual Manufacturing Co., Inc., and GKM Siebtechnik GmbH. Key opportunities in the spatial omics market include development of spatial omics assays and kits specific to various disease areas. This will help facilitate broader adoption of the technology across diagnostic and clinical settings. Growing investments by pharmaceutical and biotech companies in spatial biology startups is another opportunity area. Globally, North America currently dominates the spatial omics market owing to significant research funding and presence of major market players. However, Asia Pacific is anticipated to emerge as the fastest growing regional market over the forecast period driven by increasing R&D spending, biotech investments and focus on precision medicine in countries like China, India and Japan. Key players are also expanding their geographical presence across emerging markets through partnerships and new facilities. Market Drivers and Restrain The key driver for the spatial omics market is increasing focus on precision medicine. Spatial omics techniques help gain molecular insights from individual cells and regions within tissues to better understand disease pathogenesis, predict treatment response and develop targeted therapies. This supports the underlying goal of precision medicine to provide personalized healthcare based on individual patient profiles. Another major driver is rising funding for spatial biology research from government and private organizations worldwide as spatial omics holds potential to accelerate drug discovery processes. The high costs of instruments and software tools required for spatial omics experiments act as a key restraint. Spatial profiling techniques currently generate large datasets requiring costly infrastructure for data analysis, storage and sharing. Limited availability of trained professionals with expertise in spatial analysis also poses a challenge. Standardization issues associated with sample preparation, data acquisition and software tools can hamper wider adoption of spatial omics methods. However, technology advancements are expected to progressively address these restraints over the coming years.

Segment Analysis

Spatial omics sub-segment dominates the market currently. Spatial omics techniques help analyze the expression of genes and proteins at a spatial level within a tissue sample. These techniques can capture molecular information from a whole tissue slice or a tissue section in its native spatial context, enabling the visualization and mapping of molecular landscapes with cellular resolution. Advances in spatial omics techniques like multiplexed ion beam imaging (MIBI), multiplexed error-robust fluorescence in situ hybridization (MERFISH), and spatial transcriptomics are driving the growth of this sub-segment. Global Analysis

North America is expected to be the fastest growing as well as the dominating regional market during the forecast period. The presence of leading spatial omics players and availability of research funding for spatial analysis from government as well as private organizations are driving the growth of the market in this region. Asia Pacific is also expected to witness high growth rate owing to increasing research activities in countries like China and India. Research institutions and pharmaceutical companies in Asia Pacific are widely adopting spatial omics techniques for applications like biomarker discovery and drug development.

Gets More Insights on, Spatial Omics Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[roshansalunke328]

QY Research Medical published a comprehensive research on Immuno Oncology Assays Kit Market, which provides a business strategies, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

[vynzresearchindia]

Global Immunoassay Market Size, Share, Demand and Growth Forecast to 2030 | VynZ Research

The Global Immunoassay Market size will reach USD 31.9 Billion by 2030 and is expected to develop at a CAGR of 7.1% during the forecast period (2022-2030), according to VynZ Research. For the forecast year 2022-2030, as well as the historical period 2018-2021, the Global Immunoassay Market has been studied.

The research report provides a comprehensive and insightful examination of the Global Immunoassay Market and includes market analysis on segmentation, dynamics, competition, and regional development. It considers the Global Immunoassay Market's CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, pricing, and other significant parameters. The forecasts in the report are based on well-established research methodology and assumptions.

Explore the recent findings of the Global Immunoassay Market by purchasing a single user PDF@ https://www.vynzresearch.com/healthcare/immunoassay-market/request-sample

Individual strategies were examined in the Global Immunoassay Market study, followed by business profiles of Global Immunoassay Market providers. The study includes an 'Industry Landscape' section that provides readers with a comprehensive view and firms’ market share analysis of major industry players in the Global Immunoassay Market.

Most of the major players in the Global Immunoassay Market are profiled in the report. The strengths and weaknesses, business developments, recent innovations, mergers and acquisitions, expansion plans, global footprint, market presence, and product portfolios of key market competitors are all covered in the company profiling section.

The following are some of the major and developing players in the Global Immunoassay Market:

·         Roche

·         Agilent Technologies

·         Abbott Laboratories

·         Thermo Fisher Scientific

·         Siemens

·         QIAGEN

·         Danaher

·         Ortho Clinical Diagnostics

·         Sysmex

·         Bio-Rad Laboratories

·         BioMérieux

·         Becton

·         Dickinson & Company

·         Mindray

Breakdown of The Segments:

The Global Immunoassay Market is segmented by Product and Service, Platform, Technology, Specimen Type, Application, End-User, and Geography in this study. This segmentation aids executives in planning their products and budgets depending on each segment's expected growth rates.

Product & Services Insight and Forecast 2022-2030

·         Analyzers

·         Reagents & Kit

·         Software

·         Services

Platform Insight and Forecast 2022-2030

·         Chemiluminescence

·         Colorimetric

·         Fluorescence

·         Radioimmunoassays

·         Others

Technology Insight and Forecast 2022-2030

·         Enzyme-Linked Immunosorbent Assays,

·         Enzyme-Linked Immunospot

·         Immuno-PCR

·         Rapid Tests

·         Western Blotting

·         Others

Specimen Type Insight and Forecast 2022-2030

·         Blood

·         Urine

·         Saliva

·         Others

Application Insight and Forecast 2022-2030

·         Infectious Diseases

·         Oncology

·         Cardiology

·         Autoimmune Disorders

·         Neonatal Screening

·         Endocrinology

·         Bone & Mineral Disorders

·         Hematology & Blood Screening

·         Toxicology

·         Others

End User Insight and Forecast 2022-2030

·         Hospitals

·         Blood Banks

·         Clinical Laboratories

·         Pharmaceutical and Biotechnology Companies & CROs

·         Research & Academic Laboratories

·         Others

Geographical Viewpoint:

The research overview provides the major industry trend and the global market's predicted volume based on the regional analysis. The elements that have driven and hampered the market's expansion are also mentioned in this market research analysis. The study is also equipped with the most advanced and effective techniques for gathering, recording, estimating, and evaluating market data.

FAQ

1.      Who are the most dominant players in the global market, and what elements are assisting them in gaining a competitive advantage?

2.      What are the strategies adopted by the key industry players to gain traction in the industry?

3.      By the end of the forecast period, what will the market size and growth rate?

4.      What are the biggest Global Immunoassay Market trends that are influencing market growth?

5.      In the global market, which segment had the biggest revenue share?

Explore More Reports by VynZ Research:

Global Patient Monitoring Device Market – Analysis and Forecast 2022-2030

Global Hernia Repair Market – Analysis and Forecast 2022-2030

Global Diagnostic Imaging Market – Analysis and Forecast 2022-2030

Global Point of Care/Rapid Diagnostic Market – Analysis and Forecast 2022-2030

About VynZ Research

VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

[healtcare]

Global Haematology and Flow Cytometry Market

Global Haematology and Flow Cytometry Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.5% during forecast period.

Global Haematology and Flow Cytometry Market Overview:

Hematology is a medical specialty that deals with the study and treatment of blood. This is concerned with the diagnosis, study, treatment, and prevention of blood diseases. Flow cytometry is an analytical tool that is used in the measurement and analysis of several physical characteristics of cells or particles suspended in a fluid using a laser beam. The method helps to subclassify cell types to decide on the best treatment plan.

Global Haematology and Flow Cytometry Market Dynamics:

Rising global incidence and prevalence of chronic diseases like blood cancer is the major driving factor for the market growth. According to the National Cancer Institute in 2018, it was being estimated that 60,300 new leukemia cases are diagnosed and the deaths are around 24,470 cases in the United States. The increasing number of HIV cases globally is an important driver for the flow cytometry market. This is because the flow cytometry technique has its direct application in HIV diagnosis. According To UNAIDS in 2017, 31.1-43.9 million people globally are living with HIV by out of which 1.8 million are newly affected with HIV. Flow cytometry uses light scattering to determine the identity of cells. Increasing adoption of flow cytometry techniques in research and academia and growing initiatives in the field of immunology and Immuno-oncology researches are expected to propel the growth of the global flow cytometry market. Growth in stem cell research and the development of high-throughput flow cytometry technologies are likely to add new opportunities for this market in the coming years. Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. A significant restraint on the flow cytometry market is the availability of cheaper and better alternatives. ELISA (enzyme-linked immunosorbent assay) and radioimmunoassay are two of these alternatives. Although flow cytometry, ELISA, and radioimmunoassay are all methods for detecting "problem cells" in a community of cells, ELISA and radioimmunoassay are less expensive and easier to use. Along with this, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth. The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Haematology and Flow Cytometry Market Segment Analysis:

The Global Haematology and Flow Cytometry Market is segment on the basis of Product, Technology and End-Users. Based on Product, the flow cytometry instruments segment is expected to dominate the global market. The segment is further classified into cell analyzers and cell sorters. It held a market share of 25% in 2020. This high share is attributed to new advancements in technology and the introduction of novel cytometers by key players. The high price of these instruments is also contributing toward the high revenue generation in this segment. Along with this, reagents and consumables also held a prominent share in 2020. Owing to their increased adoption in diagnostics and research the segment is expected to register lucrative growth over the forecast period. The large share of this segment is mainly attributed to the growing research activities to develop and prove the efficacy of various assays and kits, and the commercialization of high-quality and application-specific consumables, reagents, and assays. Based on technology, the cell-based flow cytometry segment held the largest market share of 76% in 2020. The highest share is due to an increase in demand for early diagnosis and increased understanding of the related benefits of cell-based assays. In addition, advances in cell-based assay technology, such as innovations in tools, labels, affinity reagents, software, and algorithms, are expected to accelerate adoption in the coming years. To know about the Research Methodology :- Request Free Sample Report

Global Haematology and Flow Cytometry Market Regional Insights:

North America dominated the global market in 2020. The region dominated the global market in 2020 by holding a market share of 39.1%. This dominance is attributed due to the United States' high healthcare spending, well-developed healthcare system, and widespread adoption of technologically advanced flow cytometry solutions. In addition, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies has generated huge demand for flow cytometry solutions for research universities and pharmaceutical companies have created a huge demand for flow cytometry solutions for research needs. APAC region is projected to exhibit highest CAGR during forecast period. This high growth can be attributed to the extensive growth in the pharmaceutical and biotechnology industries of emerging economies, such as China and India. The lucrative growth exhibited by this region is also an outcome of continuous government support for the establishment of the pharmaceutical industry in emerging countries. The report also helps in understanding Global Haematology and Flow Cytometrys Market dynamics, structure by analyzing the market segments and project the Global Haematology and Flow Cytometrys Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Haematology and Flow Cytometrys Market make the report investor’s guide.

Global Haematology and Flow Cytometry Market, key developments:

• In September 2018, the U.S. FDA awarded a grant of ~$18 million over a period of four years for 12 new clinical trials. These clinical trials are aimed at developing products for patients with rare diseases (including primary sclerosing cholangitis, stargardt disease, Cushing disease, acute myeloid leukemia, and graft versus host disease, among others). • In March 2017, Cytek Biosciences Inc., a manufacturer and supplier of flow cytometry products and services launched its DxP Athena flow cytometry system. The system is compact, powerful, easy-to-use cell analyzer that are typically only found in conventional instruments that come with a much higher price tag. The DxP Athena makes the benefits of flow cytometry which are more readily available to larger number of researchers by its compact size. • In 2016, the Global Clinical Trials Fund (U.K.) launched a dedicated fund with an upper limit of $662,185 to support clinical trials across the world related to the testing of new experimental drugs and existing drugs developed for dementia.

Global Haematology and Flow Cytometry Market Scope: Inquire before buying

Global Haematology and Flow Cytometry Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Haematology and Flow Cytometry Market, Key players:

• Becton, Dickinson and Company • Beckman Coulter, Inc. • Bio-Rad Laboratories, Inc. • Thermo Fisher Scientific, Inc. • Merck KGaA • Sysmex Partec GmbH • Luminex Corporation • Miltenyi Biotec GmbH • Sony Biotechnology • Abbott • Agilent Technologies • CellaVision • Horiba • Nihon Kohden • Ortho-Clinical Diagnostics • Roche • Siemens Healthineers • Sysmex • Miltenyi Biotec • Apogee Flow Systems Ltd.

[techscimarketresearch]

North America to Dominate the Global Allergy Diagnostics Market till 2026 | TechSci Research

Increasing geriatric population and expansion of healthcare sector is expected to drive the demand for global allergy diagnostics market in the forecast period.

According to TechSci Research report, “Global Allergy Diagnostics Market By Product (Assay Kits, Instruments, Consumables, Services) By Allergy Type (Food, Seasonal, Drug, Inhalant, Anaphylaxis/Contact Allergies, Others) By Test (In Vivo, In Vitro) By End User (Hospital, Diagnostic Laboratory, Academic and Research Institutes, Others) By Company, By Region, Forecast & Opportunities, 2026”, global allergy diagnostics market is expected to witness steady growth for the upcoming five years. Allergy diagnostics is a crucial step to identify the type of allergy in patients suffering from allergy diseases such as asthma, eczema, conjunctivitis, among others. Allergies cause both direct and indirect economical burden on the patient. Direct costs comprise of healthcare and medical facilities cost occurred due to allergy diseases and indirect costs comprises of loss of work, taxation income, loss of productivity and sometimes huge impacts on job status of patients. Therefore, timely and proper diagnostics of allergy aids in proper and early treatment which is considered a major influencing factor for high market growth during the forecast period.

Government’s initiatives to promote healthcare sector and raise awareness regarding the disadvantages of allergies is fostering the allergy diagnostics market. Alarming rise of pollution across the globe and related diseases are leading the demand for allergy diagnostics market. Increasing number of children below 14 years of age are highly prone to allergy diseases. Implementation of allergy diagnostics equipment, which are technologically advanced, aids in high accuracy and great results. Increasing incidences of diseases caused by food allergens due to sedentary lifestyle of consumers, which leaves less time left for cooking purpose and created the market for unhealthy food habits such as junk food, is accelerating the global allergy diagnostics market. Due to the introduction of advanced technology, blood tests and other related tests are introduced which lower the risks of body catching allergies. Government’s initiatives to launch reimbursements and healthcare services support plans is aiding to increase the demand for allergy diagnostics.

However, strict regulations by government and huge capital requirements may create hindrances in the global allergy diagnostics market growth.

Browse XX Figures spread through XX Pages and an in-depth TOC on "Global Allergy Diagnostics Market”.

https://www.techsciresearch.com/report/allergy-diagnostics-market/7424.html

Global allergy diagnostics market is segmented into product, allergy type, test, end user, region, and company. Based on product, the market is further divided into assay kits, instruments, consumables, and services. Assay kits are expected to dominate the market for the forecast period, 2022-2026, owing to the availability and high demand for allergy diagnostics procedures. Assay kits are more sensitive and provide personalized patient monitoring and profiling which is paving the way for allergy diagnostics market. Based on end user, the market is fragmented majorly into hospital, diagnostic laboratory, academic and research institutes, and others. Diagnostic laboratory is anticipated to hold major market share due to high demand from emerging economies.

Increasing order of allergy diseases in major countries is fostering the high market demand. Advancements in screening techniques to get better diagnosis results and appropriate treatment is a major driver for the allergy diagnostics market around the world. Based on allergy type, the market is majorly divided into food, seasonal, drug, inhalant, anaphylaxis/contact allergies and others. The inhalant segment is expected to hold major market share due to the high prevalence of respiratory diseases and asthma across the globe. Introduction of specific allergen for detection of allergy and high demand for allergy testing due to increased health awareness is aiding the allergy diagnostics market growth. Based on test, the market is categorized into in-vivo and in-vitro tests. In-vivo is expected to hold a major share due to easy use, time efficient nature and highly sensitive nature.

Thermo Fisher Scientific Inc., Siemens Healthineers AG, Danaher Corporation, Omega Diagnostics Group PLC, bioMérieux SA, Stallergenes Greer Ltd., HYCOR Biomedical LLC, Lincoln Diagnostics Inc., Indoor Biotechnologies Inc., Terumo Medical Corporation Ltd., R-Biopharm AG, Diagenics Ltd., Biomerica, Inc., Bio-Diagnostics Ltd., EUROIMMUN AG are the leading players operating in the global allergy diagnostics market. Manufacturers are increasingly focusing on research and development processes to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several allergy diagnostics manufacturers are coming up with their technologically advanced offerings.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7424

Customers can also request for 10% free customization on this report.

“Laboratory services prefer allergy diagnostics services with quicker turn around time and is considered an important parameter to determine laboratory performance. Adoption of automated and semi-automated technology to reduce the turn around time and obtain early results for quick and efficient treatment is boosting the market demand at global level. High-end investments by major players of allergy diagnostics to provide accurate and elaborate result which is propelling the market growth until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Allergy Diagnostics Market By Product (Assay Kits, Instruments, Consumables, Services) By Allergy Type (Food, Seasonal, Drug, Inhalant, Anaphylaxis/Contact Allergies, Others) By Test (In Vivo, In Vitro) By End User (Hospital, Diagnostic Laboratory, Academic and Research Institutes, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of global allergy diagnostics market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global allergy diagnostics market.

Browse Related Reports:

Global Veterinary Immunodiagnostics Market By Product Type (Analyzers, Consumables) By Animal Type (Livestock (Cattle, Pigs, Poultry, Others), Companion (Feline, Equine, Canine, Others) By Technology (ELISA, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Colorimetric Immunoassay), Radioimmunoassay, Rapid Tests, Others) By Application (Infectious Disease, Autoimmune Disorder, Endocrinology, Oncology, Bone and Mineral Diseases, Others) By End User (Reference Laboratories, Academic and Research Institutes, Veterinary Hospitals & Clinics, Point of care/In-house testing) By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores and E-Commerce) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/veterinary-immunodiagnostics-market/7352.html

India In Vitro Diagnostics Market By Product (Instrument, Reagent, Other Products), By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, Other Types), By Usability (Disposable In Vitro Diagnostics Devices, Reusable In Vitro Diagnostics Devices), By Application (Infectious Disease, Diabetes, Oncology, Cardiology, Autoimmune Disease, Nephrology, Others), By End User (Diagnostic Laboratories, Hospitals & Clinics, Others), By Company, By Region, Forecast & Opportunities, FY2026

https://www.techsciresearch.com/report/india-in-vitro-diagnostics-market/7302.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[rdagade]

Global Haematology and Flow Cytometry Market

Global Haematology and Flow Cytometry Market

is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.5% during forecast period.

Global Haematology and Flow Cytometry Market Overview:

Hematology is a medical specialty that deals with the study and treatment of blood. This is concerned with the diagnosis, study, treatment, and prevention of blood diseases. Flow cytometry is an analytical tool that is used in the measurement and analysis of several physical characteristics of cells or particles suspended in a fluid using a laser beam. The method helps to subclassify cell types to decide on the best treatment plan.

Global Haematology and Flow Cytometry Market Dynamics:

Rising global incidence and prevalence of chronic diseases like blood cancer is the major driving factor for the market growth. According to the National Cancer Institute in 2018, it was being estimated that 60,300 new leukemia cases are diagnosed and the deaths are around 24,470 cases in the United States. The increasing number of HIV cases globally is an important driver for the flow cytometry market. This is because the flow cytometry technique has its direct application in HIV diagnosis. According To UNAIDS in 2017, 31.1-43.9 million people globally are living with HIV by out of which 1.8 million are newly affected with HIV. Flow cytometry uses light scattering to determine the identity of cells.

Increasing adoption of flow cytometry techniques in research and academia and growing initiatives in the field of immunology and Immuno-oncology researches are expected to propel the growth of the global flow cytometry market. Growth in stem cell research and the development of high-throughput flow cytometry technologies are likely to add new opportunities for this market in the coming years. Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. A significant restraint on the flow cytometry market is the availability of cheaper and better alternatives.

ELISA (enzyme-linked immunosorbent assay) and radioimmunoassay are two of these alternatives. Although flow cytometry, ELISA, and radioimmunoassay are all methods for detecting "problem cells" in a community of cells, ELISA and radioimmunoassay are less expensive and easier to use. Along with this, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth.

The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Haematology and Flow Cytometry Market Segment Analysis:

The Global Haematology and Flow Cytometry Market is segment on the basis of Product, Technology and End-Users. Based on Product, the flow cytometry instruments segment is expected to dominate the global market. The segment is further classified into cell analyzers and cell sorters. It held a market share of 25% in 2020. This high share is attributed to new advancements in technology and the introduction of novel cytometers by key players. The high price of these instruments is also contributing toward the high revenue generation in this segment. Along with this, reagents and consumables also held a prominent share in 2020. Owing to their increased adoption in diagnostics and research the segment is expected to register lucrative growth over the forecast period. The large share of this segment is mainly attributed to the growing research activities to develop and prove the efficacy of various assays and kits, and the commercialization of high-quality and application-specific consumables, reagents, and assays.

Based on technology, the cell-based flow cytometry segment held the largest market share of 76% in 2020. The highest share is due to an increase in demand for early diagnosis and increased understanding of the related benefits of cell-based assays. In addition, advances in cell-based assay technology, such as innovations in tools, labels, affinity reagents, software, and algorithms, are expected to accelerate adoption in the coming years.

To know about the Research Methodology :-

Request Free Sample Report

Global Haematology and Flow Cytometry Market Regional Insights:

North America dominated the global market in 2020. The region dominated the global market in 2020 by holding a market share of 39.1%. This dominance is attributed due to the United States' high healthcare spending, well-developed healthcare system, and widespread adoption of technologically advanced flow cytometry solutions. In addition, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies has generated huge demand for flow cytometry solutions for research universities and pharmaceutical companies have created a huge demand for flow cytometry solutions for research needs. APAC region is projected to exhibit highest CAGR during forecast period.

This high growth can be attributed to the extensive growth in the pharmaceutical and biotechnology industries of emerging economies, such as China and India. The lucrative growth exhibited by this region is also an outcome of continuous government support for the establishment of the pharmaceutical industry in emerging countries. The report also helps in understanding Global Haematology and Flow Cytometrys Market dynamics, structure by analyzing the market segments and project the Global Haematology and Flow Cytometrys Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Haematology and Flow Cytometrys Market make the report investor’s guide.

Global Haematology and Flow Cytometry Market, key developments:

• In September 2018, the U.S. FDA awarded a grant of ~$18 million over a period of four years for 12 new clinical trials. These clinical trials are aimed at developing products for patients with rare diseases (including primary sclerosing cholangitis, stargardt disease, Cushing disease, acute myeloid leukemia, and graft versus host disease, among others). • In March 2017, Cytek Biosciences Inc., a manufacturer and supplier of flow cytometry products and services launched its DxP Athena flow cytometry system. The system is compact, powerful, easy-to-use cell analyzer that are typically only found in conventional instruments that come with a much higher price tag. The DxP Athena makes the benefits of flow cytometry which are more readily available to larger number of researchers by its compact size. • In 2016, the Global Clinical Trials Fund (U.K.) launched a dedicated fund with an upper limit of $662,185 to support clinical trials across the world related to the testing of new experimental drugs and existing drugs developed for dementia.

For more information visit@ https://www.maximizemarketresearch.com/market-report/global-haematology-and-flow-cytometry-market/98749/

Global Haematology and Flow Cytometry Market Scope: Inquire before buying

Global Haematology and Flow Cytometry Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Haematology and Flow Cytometry Market, Key players:

• Becton, Dickinson and Company • Beckman Coulter, Inc. • Bio-Rad Laboratories, Inc. • Thermo Fisher Scientific, Inc. • Merck KGaA • Sysmex Partec GmbH • Luminex Corporation • Miltenyi Biotec GmbH • Sony Biotechnology • Abbott • Agilent Technologies • CellaVision • Horiba • Nihon Kohden • Ortho-Clinical Diagnostics • Roche • Siemens Healthineers • Sysmex • Miltenyi Biotec • Apogee Flow Systems Ltd.

This report submitted by Maximize market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908

[sandlerresearch]

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025 published on

https://www.sandlerresearch.org/in-vitro-diagnostics-market-by-product-service-instrument-kits-technology-immunoassay-mdx-hematology-urinalysis-application-diabetes-oncology-cardiology-nephrology-infectious-diseases.html

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025

“The in vitro diagnostics market is projected to grow at a CAGR of 2.6%.”

The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period.Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices.

“By technology, within the IVD market, immuno assays segment holds the largest share in the forecast period.”

Based on technology, the in vitro diagnostics market has been segmented into immuno assays, clinical chemistry, molecular diagnostics, microbiology, hematology, urinalysis, coagulation and others. Immuno assays accounted for the largest share of the market in 2019. Significant market share can be associated with increasing investments of leading players such as Roche Diagnostics, Danaher Corporation, Abbott Laboratories, and others in developing superior quality immuno assays. These immun oassays are highly reliable and provide healthcare professionals with an accurate diagnosis that positively impacts the segment all growth.

“By application, the oncology segment is expected to grow at the fastest rate during the forecast period (2020-2025)”

Based on application, the in vitro diagnostics market has been segmented into infectious disease, oncology, diabetes, cardiology, drug testing, HIV/AIDS, auto-immune diseases, nephrology and others.The oncology segment is predicted to have higher growth rate as compared to other applications due to increasing prevalence of cancer in developed as well as developing countries.  According to WHO, cancer is the second leading cause of death and there is an exponential increase in the number of cancer cases since past few years. This scenario proves beneficial for the segment growth as it increases the demand for efficient diagnostic tests, thereby, surging the overall industry growth.

“North America to hold the largest share.”

North America is expected to account for the largest share of the global in vitro diagnostics market in 2019.The large share of this region can primarily be attributed to the presence of a well-established base of IVD companies, high investments in the IVD devices and software, and increasing R&D expenditure. On the other hand, the APAC is expected to witness the highest CAGR during the forecast period due to the large number of research activities, low cost of operations in APAC countries, and large elderly population base.

The breakdown of primary participants is mentioned below:

By Company Type: Tier 1–30%, Tier 2–45%, and Tier 3–25%

By Designation: C-level–35%, Director Level–25%, and Others–40%

By Region: North America–35%, Europe–30%, the Asia Pacific–15%,Latin America–10%, Middle East & Africa – 10%

Research Coverage:

The report analyzes the various in vitro diagnostics products and their adoption patterns in different applications. It aims at estimating the market size and future growth potential of the global in vitro diagnostics market for different segments such as by products and services, technology, application, end-users and regions. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which would help the magner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in vitro diagnostics market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities,and product launches in the global in vitro diagnostics market

Market Development: Comprehensive information on lucrative emerging regions,by products and services, application, technology, end-users.

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global in vitro diagnostics market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and services offered by leading players in the global in vitro diagnostics market

[captainmariawilliams-blog]

Global Immuno Oncology Assays Kit Market 2019 Innovative Trends and Insights Research upto 2024

Research study on Global Immuno Oncology Assays Kit Market - Examination of Market Segmentation Including Product Type, Application, And Regions

Global Immuno Oncology Assays Kit Market Growth 2019-2024 delivers  compilation for the market, which primarily focuses on the market trends, demand spectrum, and prospects of this industry over the forecast period from 2019 to 2024. The report comprises wide-ranging information about the market overview, top vendors, key market highlights, product types, market drivers, challenges, trends, Immuno Oncology Assays Kit industry landscape, size and forecast, five forces analysis, key leading countries/region. The report passes on a sketch-view of the market base and extensions, and statistical overview in terms of trends outlining the geographical opportunities and contributions by prominent industry share contenders. In short, the report evidently illustrates its encouraging or obtrusive points for global and regional growth.

DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report/global-immuno-oncology-assays-kit-market-growth-2019-2024-380008.html#sample

Brief of The Market Segmentation:

As per the product type, the Immuno Oncology Assays Kit market is categorized and the market share of each product along with the project valuation is mentioned in the report. The report consists of facts related to every single product's sale price, revenue, growth rate over the estimation period. According to the application spectrum, the market is categorized and the data pertaining the market share of each product application as well as estimated revenue that each application registers for is mentioned in the report.

Market share of global Immuno Oncology Assays Kit industry is dominated by companies like , Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina  and others which are profiled in this report as well in terms of sales, price, revenue, gross margin and market share.

As per the report, in terms of provincial scope, the market is divided into Americas (United States, Canada, Mexico, Brazil),  APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia, Spain), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries) the product's usage throughout the geographical landscape.

READ FULL REPORT:  https://www.fiormarkets.com/report/global-immuno-oncology-assays-kit-market-growth-2019-2024-380008.html

Specifics Are Given In The Report:

The study delivers a detailed evaluation of drivers which may influence the profit scale of this industry positively.

The estimated remuneration of the application segments delivered in the report

Revenue estimation of each product segment

Market share which every application segment may hold over the projected period

Consumption market share impacting every application type

The study also gives information pertaining to the elaborate number of challenges that may constrain the Immuno Oncology Assays Kit market expansion.

The anticipated surge in consumption rates over the projected years, spanning the geographies listed

The report reveals that product launches have been an essential strategy adopted by the industry players in the Immuno Oncology Assays Kit market. To stay ahead in the competition, the market leaders are using competitive advancements such as joint ventures, strategic association, collaboration and acquisitions, new product development, and research. Market vital features covered in this report include revenue, capacity application rate, expenditures, manufacturing, price, gross, growth ratio, supply, industry demand, export, and import study, and CAGR up to 2024.

Customization of the Report: This report can be customized to meet the client’s requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements

[marketresearchlove-blog]

Asia-Pacific Immunoassay Reagents and Devices Market

Asia-Pacific Immunoassay Reagents and Devices Market By Product (Reagents & Kits, Analyzers), Platform (Enzyme Immunoassay, Fluorescence Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassays, Others), Technique (Enzyme-Linked Immunosorbent Assays, Enzyme-Linked Immunospot, Rapid Tests, Western Blotting, Immuno-PCR, Other), Specimen Type (Blood, Urine, Saliva, Others), Application (Oncology and Endocrinology, Hematology & Blood Screening, Cardiology, Infectious Diseases, Bone & Mineral Disorders, Autoimmune Disorders, Toxicology, Neonatal Screening, Other Applications), End User (Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Hospitals, Research & Academic Laboratories, Blood Banks, Others), Countries (China, Japan, India, South Korea, Australia, Malaysia, Singapore, Thailand, Indonesia, Philippines and rest of Asia-Pacific),Market Trends and  Forecast to 2027.

Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-immunoassay-reagents-and-devices-market

Market Analysis and Insights: Asia-Pacific Immunoassay Reagents and Devices Market

Asia-Pacific immunoassay reagents and devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a highest CAGR of 7.1% the forecast period of 2020 to 2027 and expected to reach USD 7,412.67 million by 2027. Rising geriatric population and increasing adoption immunoassay in emerging market is the factors for the market growth.

Immunoassay plays an important role in diagnosis of disease and also helps in drug discovery and hence used in many pharmaceutical as well as biotechnology industries. Rising geriatric population with number of diseases in Asia-Pacific is one of the major factors which is helping the market to grow. With the advancement in immunoassay devices, nowadays it is easy to diagnose diseases which lead the demand for the market. Increasing geriatric population in Asia can be driving factor for the growth for the market. Increasing geriatric population with high incidence of disease requires detection for further treatment. For instance, according to UNFPA, older persons aging over 60 in the Asia region will triple between 2010 and 2050 which is approximately to 1.3 billion people. Most of the aging population suffer from disease in which testing is required.

This immunoassay reagent and devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

 Asia-Pacific Aluminum Casting Market Size, Status and Forecast 2018 – 2025

 ·         Asia-Pacific Aluminum Casting Market Overview

 ·         Asia-Pacific Aluminum Casting Market Manufacturers Profiles

 ·         Asia-Pacific Aluminum Casting Market Sales, Revenue, Market Share and Competition by Manufacturer

 ·         Asia-Pacific Aluminum Casting Market Analysis by Regions

 ·         Asia-Pacific Aluminum Casting Market by Countries

 ·         Asia-Pacific Aluminum Casting Market Segment by Type

 ·         Asia-Pacific Aluminum Casting Market Segment by Application

 ·         Asia-Pacific Aluminum Casting MarketForecast

 ·         Sales Channel, Distributors, Traders and Dealers

 ·         Research Findings and Conclusion

 ·         Appendixes

Get Detailed Toc @https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-immunoassay-reagents-and-devices-market

Asia-Pacific Immunoassay Reagents and Devices Market Scope and Market Size

Asia-Pacific immunoassay reagents and devices market is segmented on the basis of by product, platform, technique, specimen type, application, and end-user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

·         On the basis of product, immunoassay reagents and devices market is segmented into reagents & kits and analyzers. In 2020, reagents & kits segment is exceeding the market due to extreme usage in disease detection and drug development. Increased diseases require proper diagnosis for further treatment. And hence, companies are developing number of kits and reagents and providing in market for further use. In November 2018, bioMérieux SA acquired the majority stake of Suzhou Hybiome Biomedical Engineering Co. Ltd. (China). The company developing in an immunoassay tests in a more advanced way to deliver high throughput analysis. This acquisition gives bioMérieux SA an opportunity to expand their product portfolio to making it even stronger diagnostic market in China.

·         On the basis of platform, immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassays, radioimmunoassays, and others. In 2020, enzyme immunoassay segment is dominating the market because of its advantages such as ease in performing test, accurate result and many others. However, chemiluminescence immunoassays are growing due to its benefits in performing assays to get accurate result.

·         On the basis of technique, immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR, and other techniques. Enzyme-linked immunosorbent assays segment is dominating because it is simple to perform, highly sensitive offer accurate result for any disease detection or in any drug development. It is one of the accurate techniques that provide better diagnosis in diseases. 

·         On the basis of specimen type, immunoassay reagents and devices market is segmented into saliva, urine, blood, and others. Blood is easy to detect and provides accurate estimation rate for a particular foreign particle.

·         On the basis of application, immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications. Oncology and endocrinology segment is dominating because of high incidence rate worldwide which can be detected easily with the use of immunoassays. Along with the detection, various pharma companies are involved in developing drugs for the treatment of diseases. These diseases can be developed by using immunoassays. Cancer incidence is rapidly growing worldwide due to aging and growing population. For instance, according to WHO, 15.0% of the people worldwide has been registered with cancer in which Asia accounts for 6.5%.

·         On the basis of end user, immunoassay reagents and devices market is segmented into hospitals, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, research & academic laboratories, and others. Pharmaceutical and biotechnology segment is dominating the market as immunoassays are mostly utilized by these industries in performing various assay development for drugs, vaccines and many others.

Competitive Landscape and Immunoassay Reagents and Devices Market Share Analysis

Asia-Pacific immunoassay reagents and devices device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, concept cars, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific immunoassay reagents and devices market.

The major players covered in the report are F. Hoffmann-La Roche Ltd, Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Siemens, Randox Laboratories Ltd., Beckman Coulter, Inc (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc, BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A., Ortho Clinical Diagnostics (a subsidiary of Carlyle Investment Management L.L.C), QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc, Agilent Technologies, Inc, Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC and others. Immunoassay reagents and devices market share data is available for Asia-Pacific. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately

Many joint ventures and developments are also initiated by the companies worldwide which are also accelerating the Asia-Pacific immunoassay reagents and devices Market.

For instance,

·         In November 2018, Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China) has launched an immunoassay system called as Mindray CL-900i Chemiluminescence Immunoassay System with advanced technology. This system provides quality immunoassay testing.  The company has increased its product portfolio that has helped in maximizing the customer base around the world. Partnership, expansion and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for immunoassay reagent and devices market products for the welfare of the patients.

Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-immunoassay-reagents-and-devices-market

Customization Available : Asia-Pacific Immunoassay Reagents and Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), product under development data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

 Buy Now @https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-immunoassay-reagents-and-devices-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

RELATED REPORTS

·         Global Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2027

·         North America Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2027

·         Europe Immunoassay Reagents and Devices Market – Industry Trends and Forecast to 2027

[researchtrendingnews]

Blood Screening Market Strategic Insights and key Business Influencing Factors | Major Players – Thermo Fisher Scientific Inc. , BioMérieux SA , Beckman Coulter, Inc. , Abbott , F. Hoffmann-La Roche Ltd.

Blood Screening Market Screening process can also be called as the first line of defense in health care field providing a safe blood supply and helping in minimizing the problems associated with transfusion-transmitted infection. Government associations from every country should establish blood donor programs to provide information and education about blood donations. Various techniques are available in the market to perform assays for detection of the problems related to health is Immunoassays (IAs) and Nucleic Acid Amplification Technology (NAT) assays. Immunoassay is categorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays andsimple single-use assays (rapid tests).

Asia Pacific blood screening market is expected to    register a healthy CAGR of 10.5% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-blood-screening-market

Competitive Analysis: Asia-Pacific Blood Screening Market

Some of the prominent participants operating in this market are Enzo Biochem Inc., Meridian Bioscience, Inc, BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc. , BioMérieux SA , Beckman Coulter, Inc. , Abbott , F. Hoffmann-La Roche Ltd (Switzerland), Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc. , among others.

 High Temperature Elastomer Market Size, Status and Forecast 2026

 Market Overview

 Manufacturers Profiles

 Blood Screening Sales, Revenue, Market Share and   Competition by Manufacturer

 Blood Screening Market Analysis by Regions

 North America Blood Screening by Countries

 Europe Blood Screening by Countries

Asia-Pacific Blood Screening by Countries

South America Blood Screening by Countries

Middle East and Africa Blood Screening by Countries

Blood Screening Market Segment by Type

Blood Screening Market Segment by Application

Blood Screening Market Forecast

Sales Channel, Distributors, Traders and Dealers

Research Findings and Conclusion

Appendixes

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-blood-screening-market

Scope of the Blood Screening Market

Asia Pacific Blood Screening Market, By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)- Industry Trends and Forecast to 2025

Screening process can also be called as the first line of defense in health care field providing a safe blood supply and helping in minimizing the problems associated with transfusion-transmitted infection. Government associations from every country should establish blood donor programs to provide information and education about blood donations. Various techniques are available in the market to perform assays for detection of the problems related to health is Immunoassays (IAs) and Nucleic Acid Amplification Technology (NAT) assays. Immunoassay is categorized into enzyme immunoassays (EIAs), chemiluminescent immunoassays (CLIAs), haemagglutination (HA)/particle agglutination (PA) assays andsimple single-use assays (rapid tests).

Asia Pacific blood screening market is expected to    register a healthy CAGR of 10.5% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation: Asia-Pacific Blood Screening Market

Global Blood Screening Market is segmented into reagents & kits, instruments and software & services. Reagents & kits are further sub segmented into NAT reagents & kits, ELISA reagents & kits and others reagents. NAT reagents is further sub segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labeling and detection reagents. ELISA reagents & kits are further sub segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) and sample diluents and wash solutions. Instruments segment are further segmented into instruments, product type and instruments, purchase type. In 2017, reagents & kits segment is expected to dominate the global blood screening market with 49.1% market share and is expected to grow at the CAGR of 9.4% in the forecast period 2018 to 2025. However, instruments segment is expected to grow at the highest CAGR of 10.2% in the forecast period,

In January 2017, F. Hoffmann-La Roche Ltd (Switzerland) launched haematology testing solution. This solution is called the cobas m 511 integrated haematology analyser. This launch marked the entry for Roche Diagnostics in the haematology market.

On the basis of disease type, the market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others. In 2017, oncology segment is expected to dominate the global blood screening market with 24.9% market sharegrowing at the highest CAGR of 10.3% in the forecast period 2018 to 2025.

In June 2018, Thermo Fisher Scientific (U.S.) launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.

On the basis of end user the market is segmented into hospitals, clinics, diagnostic centers, blood bank and ambulatory surgical cenetrs. In 2017, diagnostic centers segment is expected to dominate the global blood screening market with 28.8% market share, growing at the highest CAGR of 10.4%in the forecast period 2018 to 2025.

In September 2016, Siemens Healthineers (Germany) acquired Conworx Technology GmbH (Germany) for point-of-care device interfaces and data management solutions. The company’s products and solutions designed helped in increasing efficiency and to reduce costs.

 Reasons to Purchase this Report:

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/Countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-blood-screening-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

[market-insights-dbmr]

Global Blood Screening Market Overview and Industry Trends 2026

Global blood screening market is expected to reach a healthy CAGR of 9.7% in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

This blood screening market research report contains the most recent market information with which companies can get in depth analysis of healthcare industry and future trends. Wide-ranging evaluation of the market growth predictions and restrictions has also been studied in this report. This blood screening market research report offers wide-ranging analysis of the market structure for healthcare industry along with estimations of the various segments and sub-segments of the market. It offers key measurements, status of the manufacturers and proves to be a significant source of direction for the businesses and organizations.

Competitive Analysis: Global Blood Screening Market

Some of the prominent participants operating in this market are Enzo Biochem Inc., Meridian Bioscience, Inc. , BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc., BioMérieux SA, Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc., among others.

Get Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-blood-screening-market

Segmentation: Global Blood Screening Market

Global blood screening market is categorized based on basis of products & services, technology, disease type and end user.

On the basis of product & services the market is segmented into reagents and kits, instruments and software & services. Reagents and kits are further sub segmented into NAT reagents & kits, ELISA reagents & kits others as well. NAT reagents is further sub segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions alsolabeling and detection reagents. ELISA reagents & kits is further sub segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments, purchase type. In 2017, reagents & kits segment is expected to dominate the global blood screening market growing at the CAGR of 9.4% in the forecast period of 2018 to 2025.

In January 2017, F. Hoffmann-La Roche Ltd launched haematology testing solution. This solution is called the cobas m 511 integrated haematology analyser. This launch marked the entry for Roche Diagnostics in the haematology market.

On the basis of technology the market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA Market, By Platform is further sub segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above. In 2017, enzyme-linked immunosorbent assay (ELISA) segment is expected to dominate the global blood screening market growing at the CAGR of 9.8% in the forecast period of 2018 to 2025.

In September 2018, Thermo Fisher Scientific Inc. (U.S.), signed a definitive agreement with BD This business combines a strong technical service program with a variety of media and other products. This acquisition helped company to expand their business on global level with larger number of products.

On the basis of disease type, the market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others. In 2017, oncology segment is expected to dominate the global blood screening marketgrowing at the highest CAGR of 10.3% in the forecast period of 2018 to 2025.

In June 2018, Thermo Fisher Scientific (U.S.) launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.

On the basis of end user the market is segmented into hospitals, clinics, diagnostic centers, blood bank and ambulatory surgical cenetrs. In 2017, diagnostic centers segment is expected to dominate the global blood screening market growing at the highest CAGR of 10.4%in the forecast period of 2018 to 2025.

In September 2016, Siemens Healthineers (Germany) acquired Conworx Technology GmbH (Germany) for point-of-care device interfaces and data management solutions. The company’s products and solutions designed helped in increasing efficiency and to reduce costs.

Product launch:

In March 2018, Bio-Rad Laboratories, Inc. launched IncRNA Workflow, a RT-qPCR workflow which is used to optimized for highly sensitive and specific quantification of long noncoding RNAs (lncRNAs) for gene expression analysis. The workflow provides a streamlined, cost-effective alternative to RNA-Seq for lncRNA discovery and validation.

In June 2018, Thermo Fisher Scientific launched Oncomine TCR Beta-SR Assay. It is a new next-generation sequencing (NGS) solution in the field of immuno-oncology research. This helped company to expand their business by enhancing their product portfolio.

In September 2018, Thermo Fisher Scientific Inc. , signed a definitive agreement with BD This business combines a strong technical services program with a variety of media and other products. This acquisition helped company to expand their business on global level with larger number of products.

Drivers: Global Blood Screening Market

RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS:

Blood transfusion is an essential component of the health care field. It helps in saving millions of lives every year in both cases of routine and emergency conditions. Below mentioned are some of the statistics for blood donation and blood donors:

According to the World Health Organization (WHO), in 2017, it was reported that 112.5 million blood donations were collected from worldwide in which approximately half of the blood was collected from developed countries.

According to the World Health Organization (WHO), in 2017, it was reported that in 1000 people, the blood donation rate was 32.1 from high-income countries, 14.9 in upper-middle-income countries, 7.8 in lower-middle-income countries and 4.6 in low-income countries.

According to Australia Red cross blood service, 606,000 donors are there in Australia which are in 1,000 locations such as collection centres for blood donation available.

RISING PREVALENCE IN NUMBER OF DISEASES:

The prevalence of diseases and conditions such as Tuberculosis, HIV infection, Intestinal nematodes, diabetes mellitus, respiratory diseases, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and many others have increased considerably over a period of time.  As numbers of diseases are increasing there is requirement for blood screening and diagnosis for further treatment of diseases.

According to WHO, alpha and beta thalassaemias are found to be the most common inherited single-gene disorders around the world. This disorder is with the highest prevalence with malaria at the places where it is endemic.As per the study conducted in Iran, it was estimated that approximately 8,000 pregnancies with risk takes place every year.

In 2016, according to Centers for Disease Control and Prevention (CDC), at the end of 2015, it was estimated 1.1 million persons with age 13 or older were suffering from HIV infection in the U.S. with an estimation of 162,500 (15.0%) persons whose infections had not been diagnosed.

In February 2018, according to verywell health, in South Africa 5,600,000 of people were estimated with HIV in 2009. In the total population of 53 million, the HIV prevalence for South Africa is found to be 10.6%.

Speak To Industry Experts, Request For Details Report At:  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-blood-screening-market

Opportunity: Global Blood Screening Market

INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING

The screening of blood involves the process that ensures whether the blood collected from people are safe or not. Based on the results of the screening, collected blood units are released for clinical research purpose or discarded if it has some contamination of bacteria or viruses or any other. For performing such screening there are different assays that help in determining the proper result.

Further with advancement, many of the other techniques are introduced with high benefits helping the market to grow in the upcoming days. The techniques are microbial screening and multiplexing technology.

Thermo Fisher Scientific (U.S.) provides microbial isolation and screening which include blood culture systems, clinical microbial identification, and microbiology specimen collection

In August 2015, Eurofins (France) launched accredited NGS tests useful for the identification of non-targeted microorganism. It helps in 16S rDNA screening for identifying the presence of microorganism communities in sample.

In July 2017, July 18, 2017–BD (Becton, Dickinson and Company) (U.S.) introduced new technologies which can automatically report and release negative urine cultures. This technology is transformed in the form of microbiology urine testing.

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email: Corporatesales@databridgemarketresearch.com

[strategyr-blog]

Critical Importance of Assaying in Research & Diagnostic Applications Drives Growth in the Global Immunoassay Systems Market

The global market for Immunoassay Systems is projected to reach US$31.6 billion by 2025, driven by critical importance of assaying in research and diagnostic applications amid growing emphasis on early diagnosis of disease conditions and development of novel biomarkers. Improving access to healthcare and testing services in developing countries is another major market driver.

Immunoassays are test procedures based on the specific immuno-reaction between an antibody and an antigen, for the determination of amount of an analyte in a test sample. Thanks to the steady expansion in immunodiagnostics, biomarker research programs, and technological advancements in the overall healthcare industry, world market for immunoassays systems evolved remarkably over the years, and continues to project a favorable outlook for the future. Rising incidence of debilitating conditions, such as diabetes, cardio-vascular ailments, infectious diseases, autoimmune disorders, allergy and cancer, fuelled the demand for immunoassay tests over the years. Multiplex immunoassay and bespoke systems widened their footprint supported by the growing need for better disease analytic procedures that offer greater efficiency and low-cost benefits.

Immunoassays market continues to benefit from fast paced technology developments which promise to bring new opportunities for growth.  Introduction of novel assays has provided a great boost to the immunoassay diagnostics market, particularly in mature markets such as the US and Europe. Therefore, the future of immunoassay market immensely relies on development of novel assays in oncology, autoimmunity and cardiology among other prominent areas, which will be primary revenue contributors for the market over the next few years. Rapid and effective tests for identification of disease conditions are fast gaining popularity and will accelerate growth in the market.

Although the forecasts remain favorable, the market has to deal with certain issues and challenges such as increasing competition from molecular assays, commoditization of ELISA Kits for various analytes, and uncertain regulatory landscape in certain application domains and regions.

As stated by the new market research report on Immunoassay Systems, the United States represents the largest market worldwide. Asia-Pacific is projected to witness the fastest growth with a CAGR of 10.7% over the analysis period, led by factors such as improving healthcare infrastructure, increased healthcare spending, focus on effective management of chronic diseases  and rising trend of medical tourism.

Major players in the market include Abbott Laboratories, Beckman Coulter Inc., bioMérieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A, Fujirebio Inc., Ortho-Clinical Diagnostics Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, and Tosoh Bioscience Inc., among others.

The research report titled “Immunoassay Systems – Market Analysis, Trends, and Forecasts” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of major companies worldwide. The report provides market estimates and projections for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America), and Rest of World. Product segments analyzed include Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.         For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn